CYP2E1 and metabolic dysfunction-associated steatotic liver disease: In animal models of NAFLD, LA reduced obesity and lipid accumulation in the liver, suppressed the expression of CYP2E1 and H2O2 production, and restored the lowered activity of antioxidant enzymes [37,38,49,50].